Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Key employees invest MSEK 6 in Checkin.com upon exercise of warrants

Exercise of warrants related to incentive programme Checkin.com Group AB (publ) (“the Company”) hereby announces that the Company's acting CEO, Christian Karlsson, has subscribed for 319,984 shares through the exercise of warrants related to the Company's incentive programme from 2020.  The Company further announces that the Company's CPO, Ebba Sidhagen Nilsson, the Company's CMO, Marcus Bengtsson, and another key employee of the Company have subscribed for 107,808, 53,328 and 115,900 shares, respectively, through the exercise of warrants related to the Company's employee stock option

Impero A/S: Notification of transactions by persons discharging managerial responsibilities and persons closely associated with them

Company Announcement No. 10-2024 - Managers‘ Transactions Copenhagen, 20 Juni 2024 Impero A/S has received notification pursuant to article 19 of regulation (EU) no. 596/2014 of the below transactions related to shares in Impero A/S made by persons discharging managerial responsibilities in Impero and/or persons closely related with them. []1. Details of the person discharging managerial responsibilities/person closely associateda) Name Profound Partners A/S2. Reason for the notificationa) Position/status

Slättö Value Add I AB (publ) announces tender offer regarding up to 100 million of its outstanding SEK bonds

NOT FOR DISTRIBUTION IN OR INTO OR TO ANY PERSON LOCATED OR RESIDENT IN THE UNITED STATES, ITS TERRITORIES AND POSSESSIONS (INCLUDING PUERTO RICO, THE U.S. VIRGIN ISLANDS, GUAM, AMERICAN SAMOA, WAKE ISLAND AND THE NORTHERN MARIANA ISLANDS, ANY STATE OF THE UNITED STATES AND THE DISTRICT OF COLUMBIA) OR TO ANY U.S. PERSON (AS DEFINED IN REGULATION S OF THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED) OR IN ANY JURISDICTION WHERE IT IS UNLAWFUL TO RELEASE, PUBLISH OR DISTRIBUTE THIS DOCUMENT. THE DISTRIBUTION OF THIS DOCUMENT IN CERTAIN JURISDICTIONS (IN PARTICULAR, THE UNITED STATES AND

New shares registered with Finnish Trade Register

Faron Pharmaceuticals Ltd (“Faron” or the “Company”) New shares of Faron registered with the Finnish Trade Register NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, NEW ZEALAND OR THE REPUBLIC OF SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL.   THIS ANNOUNCEMENT IS FOR INFORMATION PURPOSES ONLY AND DOES NOT CONSTITUTE OR CONTAIN ANY INVITATION, SOLICITATION, RECOMMENDATION, OFFER OR ADVICE TO ANY PERSON TO ACQUIRE ANY SECURITIES. PLEASE SEE THE

Supermassive black hole appears to grow like a baby star

[ Artists impression A spiralling wind helps the supermassive black hole in galaxy ESO320G030 to grow assisted by magnetic fields In this illustration the core of the galaxy is dominated by a rotating wind of dense gas leading outwards from the hidden supermassive black hole at the galaxys very centre The motions of the gas traced by light from molecules of hydrogen cyanide have been measured with the ALMA telescope] Supermassive black holes pose unanswered questions for astronomers around the world, not least “How do they grow so big?” Now, an international team of astronomers,

Clinical Laserthermia Systems publishes supplementary prospectus regarding ongoing rights issue

Clinical Laserthermia Systems AB (publ) (“CLS” or the ”Company”) has drafted a supplementary prospectus (the ”Supplementary Prospectus”) to the EU growth prospectus approved and registered by the Swedish Financial Supervisory Authority (SW: Finansinspektionen) on June 10, 2024 (the “Prospectus”). The Supplementary Prospectus has today, June 20, 2024, been approved and registered by the Swedish Financial Supervisory Authority.The Prospectus has been drafted in connection with the ongoing rights issue of units consisting of new B-shares and warrants of series TO 7 B, which was resolved by the

Metsä Group’s Kemi bioproduct mill is back in production

Metsä Group’s Kemi bioproduct mill has been restarted in stages and the mill has returned to production. The repair work caused by the gas explosion in the mill’s evaporation plant in March has been completed, and other annual maintenance work was done during the production shutdown. To ensure the high usability and the planned lifespan of the evaporation plant, the units damaged in the explosion will be completely replaced at a later date to be determined. The bioproduct mill is now continuing to increase production according to start-up plan.

Correction - Brain+ receives guarantee commitment from health tech specialized German investment boutique and additional subscription from management in its ongoing rights issue

The company announcement made by Brain+ A/S at 12:37 today contained an inadvertent error in that the DKK 150,000 subscription from management is a general subscription commitment and does not therefore increase the guaranteed coverage of the rights issue. That coverage is correctly stated as currently being 64.4%.The correct company announcement follows below:Copenhagen, Denmark, 20 June 2024 – Brain+ A/S (Nasdaq First North: BRAINP)This announcement constitutes inside information that Brain+ A/S is obliged to make public pursuant to the EU Market Abuse Regulation (EU no. 596/2014).

Aker Solutions ASA: Sale of own shares for employee share purchase program

June 20, 2024 – Aker Solutions ASA (“Aker Solutions”) has sold own shares in connection with the company’s employee share purchase program for 2024.The program entitles employees of the company in Norway to purchase shares of Aker Solutions for an amount up to NOK 60,000. Shares are offered at a maximum discount of NOK 7,500 (discount not to exceed 25 percent of the subscription amount) per participant for the entire 2024 program.  Allocation of shares to participants is quarterly; in March, June, September and December 2024. In addition, participants who remain employed and have not

Veidekke: Building commercial building for Kitron in Arendal

Veidekke is to build a production building for Kitron at Longum Park in Arendal. The agreement with AFK Eiendom, a wholly owned subsidiary of Arendals Fossekompani, is a design and build contract with a contract price of NOK 110 million excl. VAT.“We appreciate the confidence shown in us and that we have agreed on solutions that allow us to start designing and building the production building for Kitron on the attractive site located next to the E18 road at Longum in Arendal. All involved parties have contributed with good input, and we are now looking forward to extending the good

Mattias Wivesson appointed Chief Procurement Officer for Fazer Group

Fazer Group’s Chief Procurement Officer (CPO) Petteri Nisonen has decided to leave Fazer. Mattias Wivesson, M.Sc. (Econ), (b. 1975) has been appointed as the company’s new CPO and member of the extended Fazer Leadership Team. He will assume his position on September 1, 2024.Mattias Wivesson has worked at Orkla since 2005 and has served as Senior Vice President at Orkla Group Procurement since 2022. Prior to this position, he served as Vice President for Orkla Group Procurement and has in addition also held several other significant procurement positions in the company during his career. “

NIB signs sustainability-linked loan with Electrolux Group

The Nordic Investment Bank (NIB) and AB Electrolux have signed a USD 150 million (approximately EUR 140 million) eight-year sustainability-linked loan. Electrolux Group was one of the first 100 companies worldwide to sign up for the Science Based Targets initiative (SBTi) and get their carbon emission reduction targets approved by SBTi back in 2018. The targets were fulfilled in 2022, three years ahead of target. New carbon emission reduction targets were approved by SBTi in 2023 in which Electrolux Group aims to reduce carbon emissions from own production facilities (Scope 1&2) by 85%

#24-70 Hubbster Group AB receives observation status

Hubbster Group AB ("the Company"), whose shares are listed on Nordic SME, published a press release on June 20, 2024, declaring that the Company have received a statement by the auditor for the annual report that there is a material uncertainty regarding the company which may be of significance for an investor’s assessment of the Company.   According to the Rules for companies whose shares are listed on Nordic SME, a company's shares can be placed under observation if there is material uncertainty about the company’s financial situation.   With reference to situation the above,

Brain+ receives guarantee commitment from health tech specialized German investment boutique and additional subscription from management in its ongoing rights issue

Copenhagen, Denmark, 20 June 2024 – Brain+ A/S (Nasdaq First North: BRAINP)This announcement constitutes inside information that Brain+ A/S is obliged to make public pursuant to the EU Market Abuse Regulation (EU no. 596/2014). The information was submitted for publication by the contact person below on 20 June 2024. Brain+ A/S (“Brain+” or the “Company”) announces that the Company has agreed to expand the top-down guarantee tranche in its ongoing rights issue of units (new shares and warrants of series TO 4) of up to DKK 8.94 million (the “Rights Issue”). The expansion is to accommodate

Webstep ASA: Mandatory notification of trade

Oslo, 20 June 2024: Reference is made to the stock exchange announcement published by Webstep ASA (the "Company") earlier today, on 20 June 2024, regarding the resolution by the Company's board of directors to increase the Company's share capital with NOK 150,135 by the issuance of 150,135 new shares, each with a par value of NOK 1.00, in order to facilitate the delivery of new shares to the option holders having exercised 150,135 options under the Company's long-term incentive program.Embro Eiendom AS, a closely related party to the Chair of the Board at Webstep, Kjell Magne Leirgulen, has

Webstep ASA: Resolution to increase the share capital following exercise of options

Oslo, 20 June 2024: Webstep ASA (the "Company") has completed an exercise window for vested options under its long-term incentive program, where in total 150,135 options have been exercised.In connection therewith, the board of directors of the Company has in a board meeting held today, on 20 June 2024, resolved to increase the Company's share capital with NOK 150,135 by the issuance of 150,135 new shares, each with a par value of NOK 1.00, in order to facilitate the delivery of new shares to the options holders having exercised options. The board of directors' resolution to increase the

New scholarships launched to support future female engineers

EMBARGO to 00.01am Friday 21 June Teesside University has announced new scholarships available to students starting their first year of an engineering-related degree.Teesside University is working in partnership with Enginuity  and RWE Sofia Offshore Wind Farm  to attract more women to study an engineering-related degree, with a view to create a more diverse talent pipeline for current and future industries in the Tees Valley. Ann Watson, CEO of Enginuity and BA (Hons) Business Studies alumna, said: “The opportunity

SRV to build 92 student apartments in Oulunkylä, Helsinki

SRV GROUP PLC     INVESTOR NEWS    20 JUNE 2024  13:00 EEST SRV to build 92 student apartments in Oulunkylä, Helsinki SRV and Kiinteistö Oy Patolan Kulma have signed an agreement for the construction of a project comprising 92 student apartments in Patola, located in the Oulunkylä district of Helsinki. The contract is worth around EUR 10 million for SRV. It will be carried out as a turnkey contract, including the design and construction of the project. The order will be recognised in SRV’s backlog in June. The project has a legally valid building permit, and the planning starts

Pagero announces global enhancements to its network

Pagero is proud to announce global enhancements to its network for strengthened compliance and security as part of a multiregional deployment strategy. These enhancements are designed to meet diverse international and regional regulatory requirements — such as the PDP requirements in France — ensuring robust data protection and secure business transactions for all customers.The core of the enhancements is a refined structure within the Pagero Network, which now features distinct, autonomous Pagero regions. Each region ensures that data remains secure and isolated, adhering strictly to both

Modul-System Revolutionises Fleet Maintenance with Modul-Connect Easy-to-Use System

Mölndal, Sweden – Modul-System, one of the global leaders in van racking and equipment for commercial vehicles, has unveiled a new feature in its Modul-Connect system: a maintenance application specifically designed to streamline maintenance management across entire fleets. This new application helps maintain tools and equipment, whether in a vehicle, in a workshop, or an onsite workstation.The maintenance feature is an extension of the Modul-Connect Asset Tracker, which allows tools to be tracked in real-time and notifies users if a tool is left behind when leaving a worksite, ensuring

Salmon Evolution ASA: New share capital registered

20 June 2024: Reference is made to the stock exchange announcement on 18 June 2024 by Salmon Evolution ASA (“Salmon Evolution” or the “Company”) regarding the private placement as described therein (the “Private Placement”) and the resolution by the Board of Directors to issue 48,666,666 new shares (the “New Shares”) in the Company as described therein pursuant to an authorisation granted by the Company’s general meeting on 5 June 2024 (the “Board Authorisation”). 1,888,266 of the New Shares issued in accordance with the Board Authorisation are subject to an extended timeline and are

Hamlet BioPharma, the innovative pharmaceutical company, with a strong portfolio of projects, for the treatment of cancer and infections, is featured in this weekend issue of The Guardian

Hamlet BioPharma was selected by Media Planet, the media agency for The Guardian, to be featured in the Health Awareness campaign, BLADDER AND BOWEL HEALTH, given the innovative work conducted by the company.   The advertorial is published in The Guardian on June 20th. The text describes Hamlet BioPharmas progress in four key areas:   1. Bladder Cancer: New drug candidate can improve therapy in bladder cancer patients. https://tinyurl.com/bdyyf5u8 2. Bladder Pain Syndrome: How to potentially treat bacterial infections — but without using antibiotics. https://tinyurl.com/

Report of payments to government agencies in 2023

Boliden is today publishing its report of payments to government agencies in accordance with Swedish Law (2015:812) on the reporting of payments to government agencies. The report encompasses payments made to government agencies in Sweden, Finland and Ireland that pertain to extractive industry operations in 2023. For further information, please contact:Klas NilssonDirector Group Communications+46 70 453 65 88klas.nilsson@boliden.com This information is information that Boliden AB is obliged to make public pursuant to the Securities Markets Act. The information was submitted

Epiprotect® Demonstrates Significantly Lower Infection Risk in Major Pediatric Study

An independent study published in the Journal of Plastic, Reconstructive & Aesthetic Surgery, conducted at Nottingham Children’s Hospital, shows positive results for Epiprotect®. The study highlights significant pain relief, safety, and quick and easy patient follow-ups. Involving 99 patients aged 0 - 18 years treated for partial-thickness burns, the study reveals that Epiprotect® has comparable acute healing outcomes to Biobrane® from Smith & Nephew, but with a significantly lower infection rate (2.6% compared to 16.4%). "It is highly significant for S2Medical that high-quality studies

There are no items matching the current filter
There are no more items matching the current filter
Back to top